Parmar, Gurdeep
Inserm · National and Kapodistrian University of Athens · Université de Lille · Centre Hospitalier Universitaire de Lille · Sorbonne Université · Hôpital Saint-Antoine · Istanbul University
2 papers on CoChatORCID 0000-0003-3148-7432
Most cited papers
- Verified
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Moreau, P., Dimopoulos, M.-A., Mikhael, J., Yong, K., Capra, M., Facon, T., Hajek, R., Špička, I., Baker, R., Kim, K., et al. (2021) · The Lancet
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 392
- Verified
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Facon, T., Dimopoulos, M.-A., Leleu, X. P., Beksac, M., Pour, L., Hájek, R., Liu, Z., Minarik, J., Moreau, P., Romejko-Jarosinska, J., et al. (2024) · New England Journal of Medicine
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 284
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free